CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

Net Sales by Sales Format

Ordinary Income

Net Income

Business Results Data (Cons.)

Unit:million yen

    
  FY 2017 FY 2018 FY 2019 FY 2020 FY 2021(Est.)
Net Sales 10,393 10,796 10,843 10,830 11,556

Cost of Sales
(% of Net Sales)

5,471
52.6%
5,753
53.3%
5,615
51.8%
5,752
53.1%
6,225
53.9%

Gross Profit
(% of Net Sales)

4,922
47.4%
5,043
46.7%
5,228
48.2%
5,077
46.9%
5,331
46.1%

SG&A expenses
(% of Net Sales)

4,068
39.1%
4,049
37.5%
4,144
38.2%
4,092
37.8%
4,317
37.4%

Operating Income 
(% of Net Sales)

854
8.2%
993
9.2%
1,083
10.0%
984
9.1%
1,015
8.8%

Ordinary Income 
(% of Net Sales)

880
8.5%
999
9.3%
1,065
9.8%
952
8.8%
1,071
9.3%

Net Income
(% of Net Sales)

467
4.5%
672
6.2%
725
6.7%
659
6.1%
701
6.1%

Net Sales by Sales Format(cons.)

Unit:million yen

  FY 2017 FY 2018 FY 2019 FY 2020 FY 2021(Est.)

Own-brand
(%)

6,402
61.6%
6,558
60.7%
6,645
61.3%
6,640
61.3%
6,850
61.8%
Overseas
(%)
2,414
23.2%
2,715
25.2%
2,996
27.6%
2,943
27.2%
3,363
29.1%
OEM Sales
(%)
1,576
15.2%
1,522
14.1%
1,201
11.1%
1,245
11.5%
1,343
11.6%
Total
(%)
10,393
100.0%
10,796
100.0%
10,843
100.0%
10,830
100.0%
11,556
100.0%

Graph Showing Financial Position

Free Cash Flow

Financial Position Data(cons.)

Unit:million yen

  
  FY 2017 FY 2018 FY 2019 FY 2020 FY 2021(Est.)

Current Assets

11,126 11,159 11,129 10,722 10,969

Fixed Assets

6,133 6,078 6,028 6,374 6,240

Total Assets
(Gross Assets)

17,259 17,237 17,157 17,097 17,209

Current Liabilities

3,052 2,914 2,651 2,583 2,434

Fixed Liabilities

1,337 1,437 1,330 1,286 1,339

Total Liabilities

4,390 4,351 3,982 3,869 3,773

Shareholders' Equity

12,868 12,886 13,175 13,227 13,436

Equity Ratio

74.6% 74.8% 76.8% 77.4% 78.1%

Cash Flow Data

Unit:million yen

  FY 2017 Fy 2018 FY 2019 FY 2020 FY 2021
(Est.)

Net cash provided by (used in) operating activities

524 797 880 1,249 1,263

Net cash provided by (used in) investing activities

△ 193 △ 598 △ 511 △ 704 △ 518

Net cash provided by (used in) financing activities

△ 652 △ 585 △ 532 △ 845 △ 437

Net increase(decrease)in cash and cash equivalents

△ 313 △ 484 △ 203 △ 343 308

Cash and cash equivalents at end of year

4,114 3,629 3,426 3,083 3,429

Free Cash Flow

331 199 368 544 745
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2017 FY 2018 FY 2019 FY 2020 FY 2021(Est.)
ROE 3.7% 5.2% 5.6% 5.0% 5.2%
EPS(yen) 50.23 72.20 77.83 71.19 77.08
BPS(yen) 1,381.40 1,383.31 1,414.36 1,454.41 1,477.29

Dividend per Share (yen)

35 37 37 37 37

Dividend Payout Ratio(cons.)

69.7% 51.2% 47.5% 52.0% 48.0%

TOP